Francesca Tettamanzi

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Paolo Bossi, Rosalba Miceli, Laura D. Locati et al. · Annals of Oncology · 2017 · 81 citations

Medicine, Oncology, Cancer Pharmacology +10

A High Protein Diet Is More Effective in Improving Insulin Resistance and Glycemic Variability Compared to a Mediterranean Diet—A Cross-Over Controlled Inpatient Dietary Study

Francesca Tettamanzi, Vincenzo Bagnardi, Panayiotis Louca et al. · Nutrients · 2021 · 74 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Prediction of Falls in Subjects Suffering From Parkinson Disease, Multiple Sclerosis, and Stroke

Ettore Beghi, Elisa Gervasoni, Elisabetta Pupillo et al. · Archives of Physical Medicine and Rehabilitation · 2018 · 72 citations

Life Sciences, Neurology, Neuroscience +14

Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer

Nicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici et al. · Gynecologic Oncology · 2022 · 69 citations · Full text

Medicine, Oncology, Pharmacology +16

The secondary bile acid isoursodeoxycholate correlates with post-prandial lipemia, inflammation, and appetite and changes post-bariatric surgery

Panayiotis Louca, Abraham S. Meijnikman, Ana Nogal et al. · Cell Reports Medicine · 2023 · 26 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +16